Enjoy complimentary customisation on priority with our Enterprise License!
The Global Transdermal Drug Delivery Market size is estimated to grow by USD 2.44 billion at a CAGR of 4.9% between 2023 and 2028.
There has been an increasing application of transdermal patches across the world. For instance, transdermal patches are widely used for managing chronic pain conditions. In addition, they offer a controlled release of analgesics directly through the skin, providing continuous pain relief for conditions such as arthritis, back pain, or neuropathic pain. Moreover, transdermal patches containing medications such as scopolamine are used to prevent motion sickness, while antiemetic patches are applied to manage nausea. Hence, such applications are positively impacting the market growth.
Technavio has segmented the market into Application, Type, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
The analgesics segment is estimated to witness significant growth during the forecast period. Analgesics segment refers to medications that relieve pain by changing the ability to sense the surroundings or alter consciousness and are sometimes called painkillers. Furthermore, these medications help to relieve different types of pain, including headaches and injuries to arthritis.
Get a glance at the market contribution of various segments Download PDF Sample
The analgesics segment was the largest segment and was valued at USD 2.66 billion in 2018. Moreover, some analgesics can be bought over the counter, and others might require an appropriate prescription. In addition, there are several types of analgesics, such as anti-inflammatory analgesics, which reduce inflammation, and opioid analgesics, which change the way the brain perceives pain. Furthermore, the demand for analgesics is increasing as the trend of using analgesics as a pain relief patch in the form of non-invasive delivery of medications through the skin surface is gaining popularity. Hence, such factors are fuelling the growth of this segment which in turn will drive the market growth during the forecast period.
The transdermal patch segment refers to a patch that contains medication and attaches to the skin. In addition, the transdermal patch is seen as a comfortable option for taking some medications when compared to having a pill or an injection. Moreover, transdermal patches are easy to use, and the appropriate usage of the transdermal patches delivers a range of drugs into the body. In addition, some of the drugs that are most often used in transdermal patches include fentanyl to relieve pain, nicotine to help with quitting smoking, and clonidine to treat high blood pressure. Furthermore, with the increase in the number of smokers globally, the usage of nicotine transdermal skin patches coupled with the increasing number of patients is fuelling the growth of this segment which in turn will drive the market growth during the forecast period.
Transdermal semisolids, including gels, creams, and ointments, have been gaining traction in the field of transdermal drug delivery. In addition, semisolid formulations can be engineered to improve skin penetration, allowing drugs to pass through the skin's layers more effectively. Moreover, gels, creams, and ointments are easy to apply and spread over the skin, providing patient convenience. In addition, compared to certain other delivery methods, semisolids can be gentler on the skin, reducing the potential for irritation or allergic reactions. As a result, these advantages have led to increased interest and research in developing transdermal semisolid formulations for various medications which is fuelling the growth of this segment which in turn drives the market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 55% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Some of the main factors that are fuelling the growth of the market in North America include the rising prevalence of targeted diseases, including chronic pain, central nervous system disorders, and cardiovascular diseases in the region, coupled with the growing use of contraceptives and the increasing number of research activities related to transdermal drug delivery systems.
In addition, the rise in the geriatric population in the region increases the demand for geriatric medicines as the transdermal drug delivery systems help deliver drugs in a controlled manner, hence increasing the effectiveness of geriatric medicines. Hence, such factors are driving the market growth in North America during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 17 market companies, including:
Boehringer Ingelheim International GmbH: The company offers transdermal drug delivery solution namely Catapres TTS.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the transdermal drug delivery market growth is the biodegradable and biocompatible materials for transdermal drug delivery. There are several advantages to the use of biodegradable and biocompatible materials in transdermal drug delivery systems such as safety, reduced environmental impact, and improved patient acceptance. In addition, biodegradable hydrogels, such as those based on polyethylene glycol (PEG) or natural polymers, including hyaluronic acid or dextran, are used to create matrices for controlled drug release through the skin.
Moreover, these hydrogels offer high water content and good biocompatibility. In addition, nitrocellulose, derived from plant-based sources, is an emerging biodegradable material used for drug delivery systems due to its biocompatibility, high surface area, and tunable properties. Moreover, these materials offer good biocompatibility and have been used in formulations for controlled drug release. Hence, such factors are driving the market growth during the forecast period.
A key factor shaping the transdermal drug delivery market growth is the robust demand for non-invasive treatment. There is an increasing preference by patients for non-invasive treatments due to reduced pain, minimal discomfort, and quicker recovery times compared with invasive procedures. In addition, this preference contributes significantly to the demand for non-invasive options. Furthermore, non-invasive treatments generally carry lower risks of complications, infections, and adverse reactions compared with invasive surgeries or procedures.
Moreover, this aspect attracts individuals seeking safer treatment alternatives. Innovations in medical technology have expanded the availability and efficacy of non-invasive treatments. In addition, technologies such as lasers, ultrasound, radiofrequency, and transdermal drug delivery systems offer effective alternatives to invasive procedures. Furthermore, non-invasive treatments often involve minimal or no downtime, allowing individuals to resume their daily activities immediately or shortly after the procedure. Hence, such factors are driving the market growth during the forecast period.
Skin irritation and allergic reactions associated with transdermal drug delivery are the key challenges hindering the transdermal drug delivery market growth. Some of the side effects of transdermal patches include skin irritation or allergic reactions at the application site affecting patient comfort and adherence. In addition, ingredients used in the adhesive, matrix, or backing of the transdermal patch can trigger skin reactions.
Moreover, adhesives, or substances in the patch formulation might cause irritation or allergic responses in certain individuals. In addition, continuous or repeated use of patches on the same area of the skin might lead to localized skin irritation, redness, or discomfort. Furthermore, failure to properly clean and dry the application site before placing the patch also contributes to skin irritation or reactions. Hence, such factors are hindering the market growth during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Transdermal Drug Delivery Market Customer Landscape
The transdermal drug delivery market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.
|
Transdermal Drug Delivery Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
168 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.9% |
|
Market Growth 2024-2028 |
USD 2.44 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
4.44 |
|
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
|
Performing market contribution |
North America at 55% |
|
Key countries |
US, Germany, France, UK, and Japan |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
3M Co., Boehringer Ingelheim International GmbH, Croda International Plc, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson, Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Radius Health Inc., Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
